CRISPR-Cas66

@CrisprCas6

Scientific explorer endowed with the DRD4 gene interlocked by irreverence, zaniness and fiery brilliance.

Los Angeles, USA
Vrijeme pridruživanja: listopad 2017.

Tweetovi

Blokirali ste korisnika/cu @CrisprCas6

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CrisprCas6

  1. 23. lis 2019.

    Great breakthrough research by / at is the next big leap in CRISPR research. Looking forward to unraveling it's potential! 👍 cc

    Poništi
  2. proslijedio/la je Tweet
    21. lis 2019.

    Today we describe prime editing, a very versatile new approach to genome editing in human cells without cutting the DNA double helix. We integrated a reverse transcriptase with a disabled CRISPR enzyme to copy virtually any edit from an engineered guide RNA into a target site...

    Prikaži ovu nit
    Poništi
  3. proslijedio/la je Tweet

    A new gene-editing tool called prime editing allows for greater precision and control over DNA edits compared to the popular CRISPR-Cas9 system.

    Poništi
  4. proslijedio/la je Tweet

    CRISPR babies: Denis Rebrikov claims his technique will offer greater benefits, pose fewer risks and be more ethically justifiable and acceptable to the public.

    Poništi
  5. proslijedio/la je Tweet
    6. velj 2019.

    New Paper: CasX enzymes comprise a distinct family of RNA-guided genome editors.

    Poništi
  6. proslijedio/la je Tweet

    The first CRISPR babies have been born, a Chinese scientist claims. There is no independent verification, but even the attempt is a massive ethical leap. Story by

    Poništi
  7. proslijedio/la je Tweet
    20. lis 2018.

    New Paper: Programmed DNA destruction by miniature CRISPR-Cas14 enzymes.

    Poništi
  8. proslijedio/la je Tweet
    18. ruj 2018.

    New Paper: A thermostable Cas9 with increased lifetime in human plasma.

    Poništi
  9. proslijedio/la je Tweet
    8. ruj 2018.

    New Paper: Systematic discovery of natural CRISPR-Cas12a inhibitors.

    Poništi
  10. proslijedio/la je Tweet
    5. ruj 2018.

    New Paper: Real-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9.

    Poništi
  11. proslijedio/la je Tweet
    1. ruj 2018.

    New Paper: CRISPR-Cas guides the future of genetic engineering.

    Poništi
  12. proslijedio/la je Tweet

    Biologists have released new evidence to support their landmark claim that they corrected a gene mutation in human embryos using CRISPR — but critics still have questions.

    Poništi
  13. proslijedio/la je Tweet
    26. lip 2018.

    New Paper: Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection.

    Poništi
  14. proslijedio/la je Tweet
    22. lip 2018.

    New Paper: Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing.

    Poništi
  15. proslijedio/la je Tweet
    21. velj 2018.

    New Paper: Enhanced proofreading governs CRISPR-Cas9 targeting accuracy.

    Poništi
  16. proslijedio/la je Tweet

    Researchers at MIT use CRISPR to delete a gene that causes high cholesterol.

    Poništi
  17. proslijedio/la je Tweet

    Novartis announced it has a gene edit deal with a company whose tech defies what’s known about biology

    Poništi
  18. proslijedio/la je Tweet
    13. stu 2017.

    Shared mechanisms among probiotic taxa: implications for general probiotic claims

    Poništi
  19. proslijedio/la je Tweet

    Researchers have engineered to edit single RNA letters in human cells.

    Poništi
  20. proslijedio/la je Tweet

    The new CRISPR rewrites single letters in genetic code instead of cutting and replacing whole chunks of DNA.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·